Last updated: 2026-09-29 07:49:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Curis Inc. (CRIS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0,83, with a market capitalisation of $2,01M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,80 to $34,80. This page covers its latest market performance, valuation, price trends and company information.
$2,01M | |
$0,84 | |
$13.180,00 | |
$0,80 | |
$0,83 | |
156,92K | |
199,44K | |
-- | |
$34,80 | |
$0,80 | |
-- | |
-- |
Curis Inc. (CRIS) last closed at $0,83 as of 2026-09-28 23:39:00, unchanged from the previous close of $0,83.
During the latest regular trading session, CRIS traded between $0,80 and $13.180,00, with a volume of 156,92K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Curis Inc. (CRIS) moved from $1,00 to $0,83, representing a decline of 16,90% ($0,17).
The stock traded between $0,80 and $1,13 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 196,50 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0,1%
CRIS is currently trading at $0,83, placing it 0,1% of the way from its 52-week low of $0,80 to its 52-week high of $34,80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 24 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Curis Inc. (CRIS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.